Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
10.54
-0.38 (-3.44%)
At close: Aug 24, 2026, 4:00 PM EDT
10.54
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$27,714
Profits / Employee
-$1,104,575
Market Cap
17.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Palatin Technologies | 29 |
| Citius Pharmaceuticals | 23 |
| CalciMedica | 16 |
| Lipocine | 14 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Pasithea Therapeutics | 5 |
LEXX News
- 8 hours ago - DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2 - Accesswire
- 7 days ago - Lexaria Bioscience enters MTA with PegBio - TheFly
- 11 days ago - Lexaria Enters a Material Transfer Agreement With PegBio - Accesswire
- 11 days ago - Lexaria Enters a Material Transfer Agreement with PegBio - TheNewswire
- 21 days ago - Lexaria Bioscience Corp trading resumes - TheFly
- 21 days ago - Lexaria Bioscience Corp trading halted, volatility trading pause - TheFly
- 23 days ago - Lexaria Bioscience Corp trading halted, news pending - TheFly
- 25 days ago - Lexaria Bioscience announces effective date for reverse stock split - TheFly